Andrea Orozco's Colleagues at QED Therapeutics
Andrea Orozco's Contact Details
HQ
650-231-4088
650-231-4088
Location
Company
QED Therapeutics
QED Therapeutics
Andrea Orozco's Company Details
QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. Our lead candidate is infigratinib, a best-in-class FGFR kinase inhibitor that has shown meaningful clinical activity in chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. We plan to develop infigratinib in additional FGFR-driven tumor types and rare disorders.
Frequently Asked Questions about Andrea Orozco
Andrea Orozco currently works for QED Therapeutics.
Andrea Orozco's role at QED Therapeutics is Office Administrator.
Andrea Orozco's email address is ***@qedtx.com. To view Andrea Orozco's full email address, please signup to ConnectPlex.
Andrea Orozco works in the Biotechnology industry.
Andrea Orozco's colleagues at QED Therapeutics are Adalynn Harris, Ray Villar, Kimberly Richards, Shugufa Afifi, Chelsea Wolfe, Dr.Meenakshi Srivastava, Jacob Mercer and others.
Andrea Orozco's phone number is 650-231-4088